These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20976059)

  • 1. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
    Kassim SH; Li H; Vandenberghe LH; Hinderer C; Bell P; Marchadier D; Wilson A; Cromley D; Redon V; Yu H; Wilson JM; Rader DJ
    PLoS One; 2010 Oct; 5(10):e13424. PubMed ID: 20976059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
    Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
    Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):28-38. PubMed ID: 28319445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-based
    Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
    Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):39-50. PubMed ID: 28319449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia.
    Chen SJ; Sanmiguel J; Lock M; McMenamin D; Draper C; Limberis MP; Kassim SH; Somanathan S; Bell P; Johnston JC; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):154-60. PubMed ID: 24070336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
    Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
    Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
    Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
    Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis.
    Guo X; Gao M; Wang Y; Lin X; Yang L; Cong N; An X; Wang F; Qu K; Yu L; Wang Y; Wang J; Zhu H; Xian X; Liu G
    EBioMedicine; 2018 Jan; 27():214-224. PubMed ID: 29289533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Xu M; Wu X; Liu Z; Ding Y; Kong W; Little PJ; Xu S; Weng J
    Biochem Biophys Res Commun; 2022 Sep; 622():163-169. PubMed ID: 35868060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia.
    Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S
    Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for familial hypercholesterolemia.
    Van Craeyveld E; Jacobs F; Gordts SC; De Geest B
    Curr Pharm Des; 2011; 17(24):2575-91. PubMed ID: 21774774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.
    Aboumsallem JP; Muthuramu I; Mishra M; De Geest B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.
    Oka K; Mullins CE; Kushwaha RS; Leen AM; Chan L
    Gene Ther; 2015 Jan; 22(1):87-95. PubMed ID: 25231173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recapitulating familial hypercholesterolemia in a mouse model by knock-in patient-specific LDLR mutation.
    Liu J; Yang F; Shang L; Cai S; Wu Y; Liu Y; Zhang L; Fei C; Wang M; Gu F
    FASEB J; 2024 Mar; 38(6):e23573. PubMed ID: 38526846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters.
    Wang J; He K; Yang C; Lin X; Zhang X; Wang Y; Liu G; Xian X
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of gene- and cell-based therapies for familial hypercholesterolemia.
    Hajighasemi S; Mahdavi Gorabi A; Bianconi V; Pirro M; Banach M; Ahmadi Tafti H; Reiner Ž; Sahebkar A
    Pharmacol Res; 2019 May; 143():119-132. PubMed ID: 30910740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.